Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle.
Open Access
- 1 August 1990
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 86 (2) , 507-515
- https://doi.org/10.1172/jci114737
Abstract
We studied papillary muscle mechanics and energetics, myosin phenotype, and ATPase activities in left ventricles from rats bearing a growth hormone (GH)--secreting tumor. 18 wk after tumor induction, animals exhibited a dramatic increase in body weight (+101% vs. controls) but no change in the ventricular weight/body weight ratio. The maximum isometric force of papillary muscles normalized per cross-sectional area rose markedly (+42%, P less than 0.05 vs. controls), whereas the maximum unloaded shortening velocity did not change. This was observed despite a marked isomyosin shift towards V3 (32 +/- 5% vs. 8 +/- 2% in controls, P less than 0.001). Increased curvature of the force-velocity relationship (+64%, P less than 0.05 vs. controls) indicated that the muscles contracted more economically, suggesting the involvement of V3 myosin. Total calcium- and actin-activated myosin ATPase activities assayed on quickly frozen left ventricular sections were similar in tumor-bearing rats and in controls. After alkaline preincubation, these activities only decreased in tumor-bearing rats, demonstrating that V3 enzymatic sites were involved in total ATPase activity. These data demonstrate that chronic GH hypersecretion in the rat leads to a unique pattern of myocardial adaptation which allows the muscle to improve its contractile performance and economy simultaneously, thanks to myosin phenoconversion and an increase in the number of active enzymatic sites.This publication has 54 references indexed in Scilit:
- BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTSThe Lancet, 1989
- THE CARDIOVASCULAR EFFECTS OF OCTREOTIDE TREATMENT IN ACROMEGALY: AN ECHOCARDIOGRAPHIC STUDYClinical Endocrinology, 1989
- Recombinant growth hormone enhances muscle myosin heavy-chain mRNA accumulation and amino acid accrual in humans.Proceedings of the National Academy of Sciences, 1989
- Insulin-like growth factors and neonatal cardiomyocyte development: ventricular gene expression and membrane receptor variations in normotensive and hypertensive ratsMolecular and Cellular Endocrinology, 1989
- Bromocriptine for an acromegalic patient. Improvement in cardiac function and carpal tunnel syndromeJAMA, 1980
- The ATPase activities of rat cardiac myosin isoenzymesFEBS Letters, 1980
- EFFECT OF EXCESSIVE SECRETION OF GROWTH HORMONE ON TISSUES OF THE RAT, WITH PARTICULAR REFERENCE TO THE HEART AND SKELETAL MUSCLEJournal of Endocrinology, 1980
- Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patientsPublished by Elsevier ,1980
- Echocardiographic assessment of cardiac anatomy and function in acromegalic patientsThe American Journal of Medicine, 1979
- Muscle Structure and Theories of ContractionProgress in Biophysics and Biophysical Chemistry, 1957